ELGX Financial Facts

Interest expense: -3.82M
Clinical and regulatory affairs: 4.02M
See Full Income Statement

See Full Balance Sheet

Endologix Inc. (ELGX) Earnings

  |   Expand Research on ELGX
Next EPS Date 10/26/16 *Est. EPS Growth Rate +27.8% *Last Qtr.
Average EPS % Beat Rate +0.1% Revenue Growth Rate +29.1% *Last Qtr.
Average % Move 1-Wk after EPS -7.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/2/16 Q216 -$0.13-$0.20 +$0.07$51M$46.3M = Details
5/9/16 Q116 -$0.25-$0.24 -$0.01$42.4M$38.78M = Details
2/22/16 Q415 -$0.22-$0.16 -$0.06$39.2M$39.97M = Details
10/26/15 Q315 -$0.13-$0.14 +$0.01$38.2M$38.12M Details
8/3/15 Q215 -$0.18-$0.13 -$0.05$39.5M$39.35M Details
4/29/15 Q115 -$0.14-$0.13 -$0.01$36.7M$37.94M Details
2/25/15 Q414 -$0.11-$0.10 -$0.01$38.8M$38.1M Details
10/30/14 Q314 -$0.13-$0.13 $0.00$37.2M$37M = Details